PEPTONIC medical AB (publ) (FRA:28L)
0.0002
0.00 (0.00%)
At close: Nov 28, 2025
PEPTONIC medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.91 | 3.74 | 15.13 | 3.57 | 10.15 | 39.31 | Upgrade |
Cash & Short-Term Investments | 0.91 | 3.74 | 15.13 | 3.57 | 10.15 | 39.31 | Upgrade |
Cash Growth | -88.94% | -75.29% | 324.40% | -64.88% | -74.17% | 9.25% | Upgrade |
Accounts Receivable | - | - | - | 7.24 | 5.17 | - | Upgrade |
Other Receivables | 2.76 | 2.74 | 6.37 | 0.93 | 1.62 | 8.35 | Upgrade |
Receivables | 2.76 | 2.74 | 6.37 | 8.18 | 6.79 | 8.35 | Upgrade |
Inventory | 6.28 | 4.99 | 16 | 15.55 | 10.32 | 6.13 | Upgrade |
Prepaid Expenses | 4.34 | 1.12 | 2.91 | 4.06 | 0.92 | 1.59 | Upgrade |
Total Current Assets | 14.3 | 12.59 | 40.42 | 31.35 | 28.19 | 55.39 | Upgrade |
Property, Plant & Equipment | 0.33 | 0.4 | 3.78 | 4.3 | 4.2 | 1.49 | Upgrade |
Goodwill | 3.59 | 4.46 | 5.63 | - | - | 23.5 | Upgrade |
Other Intangible Assets | 9.5 | 9.85 | 9.97 | 7.72 | 7.29 | 7.25 | Upgrade |
Long-Term Deferred Charges | 40.28 | 43.26 | 46.94 | 42.38 | 44.92 | 46.83 | Upgrade |
Other Long-Term Assets | 0 | - | - | 0 | - | - | Upgrade |
Total Assets | 68 | 70.56 | 106.74 | 85.75 | 84.6 | 134.44 | Upgrade |
Accounts Payable | 5.1 | 3.35 | 7.56 | 4.18 | 6.22 | 3.78 | Upgrade |
Accrued Expenses | 2.67 | 1.37 | 4.5 | 5.88 | 7.03 | 4.7 | Upgrade |
Short-Term Debt | 15.58 | 12.58 | 13.78 | 19.33 | 15.35 | - | Upgrade |
Current Income Taxes Payable | - | - | - | 0.24 | 0.19 | - | Upgrade |
Other Current Liabilities | 5.83 | 4.71 | 5.58 | 5.43 | 2.69 | 8.13 | Upgrade |
Total Current Liabilities | 29.18 | 22.01 | 31.41 | 35.07 | 31.48 | 16.62 | Upgrade |
Other Long-Term Liabilities | - | 0 | -0 | 3.6 | - | - | Upgrade |
Total Liabilities | 29.18 | 22.01 | 31.41 | 38.66 | 31.48 | 16.62 | Upgrade |
Common Stock | 42.95 | 40.32 | 38.37 | 24.27 | 19.16 | 16.29 | Upgrade |
Additional Paid-In Capital | 374.26 | 363.62 | 333.04 | 273.61 | 248.44 | 240.4 | Upgrade |
Retained Earnings | -378.39 | -355.82 | -301.47 | -258.19 | -224.1 | -152.38 | Upgrade |
Comprehensive Income & Other | - | 0.44 | 5.38 | 7.39 | 9.62 | 13.51 | Upgrade |
Shareholders' Equity | 38.83 | 48.55 | 75.32 | 47.09 | 53.12 | 117.82 | Upgrade |
Total Liabilities & Equity | 68 | 70.56 | 106.74 | 85.75 | 84.6 | 134.44 | Upgrade |
Total Debt | 15.58 | 12.58 | 13.78 | 19.33 | 15.35 | - | Upgrade |
Net Cash (Debt) | -14.67 | -8.84 | 1.36 | -15.77 | -5.19 | 39.31 | Upgrade |
Net Cash Growth | - | - | - | - | - | 9.37% | Upgrade |
Net Cash Per Share | -0.00 | -0.00 | 0.00 | -0.06 | -0.03 | 0.24 | Upgrade |
Filing Date Shares Outstanding | 9,337 | 9,337 | 1,535 | 242.74 | 191.64 | 162.91 | Upgrade |
Total Common Shares Outstanding | 9,337 | 5,759 | 1,535 | 242.74 | 191.64 | 162.91 | Upgrade |
Working Capital | -14.88 | -9.42 | 9 | -3.71 | -3.3 | 38.77 | Upgrade |
Book Value Per Share | 0.00 | 0.01 | 0.05 | 0.19 | 0.28 | 0.72 | Upgrade |
Tangible Book Value | 25.73 | 34.24 | 59.72 | 39.37 | 45.83 | 87.08 | Upgrade |
Tangible Book Value Per Share | 0.00 | 0.01 | 0.04 | 0.16 | 0.24 | 0.53 | Upgrade |
Machinery | 0.79 | 0.88 | 5.74 | 5.34 | 4.85 | 1.83 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.